Enzymology external website

·  Research Grant 548PED/2020-2022 from UEFISCDI for "Development of a functional model of a neutron activator (NA) controlled by a cyclotron to obtain a radiopharmaceutical based on an affibody coupled to a surface of activated nanoparticles", Partner (P) team, PN-III-P2-2.1-PED-2019-4184;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr.Szedlacsek Horea Stefan, PhD Student: Puiu Adina Gabriela, PhD Student: Vasilescu Andrei- Mihai

·  Research Grant 35PCCDI/2018-2021 from UEFISCDI for „Genomic mapping of population in area contaminated with radioactivity and heavy metals”, Partner 3, PN-III-P1-1.2-PCCDI-2017-0737;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr. Ionescu Aura-Elena, Research assistant: Dr.Szedlacsek Horea Stefan, PhD Student: Puiu Adina-Gabriela, PhD Student: Vasilescu Andrei-Mihai, Assistant technician: Donțu Otilia Cristina.

·  Research Grant 64PCCDI/2018-2021 from UEFISCDI for „Development of radio-pharmaceuticals and nuclear technics in oncology for imaging and personalized therapy at molecular level”, Partner 1, PN-III-P1-1.2-PCCDI-2017-0769;

Project team: Partner Project Manager: Dr.Szedlacsek Stefan Eugen, Researcher: Dr. Badea Rodica-Aura, PhD Student Bănică Alexandra Maria, Assistant technician: Bică Cătălin-Constantin

In Fig.8.1: Atributul de biomarker in leucemia acuta pe celule mieloide monocitare MLL-AF9 al Ly6C

1. Experiment-based design of lead compounds with potential cognitive enhancement effect

• Dr Rodica Badea
• Dr Horea Szedlacsek

The decline of cognitive capacity is one of the most debilitating features of neurodegenerative diseases. To a great extent, this is due to changes in the molecular composition of postsynaptic membranes which in turn leads to reduced synaptic plasticity. Synaptic function depends on synaptic plasticity which can either potentiate or depress information transfer. As a rule, high-frequency stimulation potentiates synaptic activity leading to long-term potentiation (LTP) while low-frequency stimulation depresses synaptic activity leading to long-term depression (LTD). Long term changes in synaptic functions can be induced by activation of NMDA receptors which modify synaptic strength through regulating the number of postsynaptic AMPA receptors (AMPAR). NMDAR activation leads to Ca2+ influx through the receptor coupled ion channel which can initiate either LTP or LTD, depending on the spatiotemporal activation profile. Cognitive impairment and learning ability of the brain is directly linked to synaptic plasticity as measured in LTP changes in animal models of brain diseases.

AMPARs are glutamate-activated ion channels which mediate the fast excitatory ion current underlying information transmission in the brain. An increase in the number of postsynaptic AMPARs leads to increased synaptic strength during LTP, while a decrease in postsynaptic AMPAR number produces LTD. Increased number of AMPAR during LTP can be mediated by both exocytosis of AMPARs and/or lateral diffusion of AMPARs from the peri-synaptic membrane to the synapse. Conversely, LTD leads to AMPAR diffusion away from the synapse and receptor endocytosis.

Post-translational modifications of AMPAR cytoplasmic region like tyrosine phosphorylation were proved to play important role in receptor trafficking and other processes so that a specific phosphorylation pattern of this receptor might be associated with a physiological or pathological state. The main idea of this project is to modulate the phosphorylation state of AMPA receptors in such a manner to favor a physiological functionality of the receptor. Eventually, we aim at identifying lead compounds with potential cognitive enhancement effect.

2. Mapping of tyrosine phosphorylation sites and functional analysis of EYA 3

• Dr.Aura Ionescu
• PhD Adina Gabriela Puiu

Eyes absent (eya) proteins are members of a regulatory network of evolutionary conserved transcription factors and cofactors, termed retinal determination gene network (RDGN) in Drosophila, along with twin of eyeless (toy), eyeless (ey), sine oculis (so) and dachshund (dac). From insects to humans, there are correspondent gene families - Pax (for toy and ey), Six (for so), Eya (for eya) and Dach (for dac) - referred to as the PSEDN (Pax-Six-Eya-Dach) network. This network holds important roles in the development and homeostasis of various tissues and organs - eyes, kidneys, nervous system, ears, muscles - as well as in the context of limb formation, gonadogenesis and neurogenesis. Loss of function mutations in the Eyes absent genes can lead to several congenital syndromes, for example cardiofacial syndrome, bronchio-oto-renal syndrome, oto-facio-cervical syndrome, congenital cataract, late onset of deafness. On the other hand, overexpression of Eyes absent has been detected in diverse types of cancers like epithelial ovarian cancer, Wilms’ tumors, lung adenocarcinoma, colorectal cancer, colon cancer, esophageal adenocarcinoma.

Post-translational modifications of EYA proteins may influence their implication in physiological and pathological events. Recently, we have demonstrated and reported that Src kinase phosphorylates human EYA1 and EYA3 and their nuclear and cytoskeletal localization are controlled by Src phosphorylation. In the same time, we have found that EYA1 and EYA3 are capable of autodephosphorylation. We have also shown that Src kinase has phosphorylation sites in both N-terminal and C-terminal domains of EYA3 protein. This data brings into discussion the implication of tyrosine phosphorylation in regulating the physiological activities of eyes absent proteins and potential interacting partners in mammalian cells. Thus, in this project we perform a detailed mass spectrometric analysis of human EYA3 phosphorylation by protein tyrosine kinase Src and analyze whether the phosphorylation sites can be autodephosphorylated. In terms of our future objectives we plan to identify the physiological impact of the phosphorylation of the detected tyrosine residues.

3. Identification of signaling mechanisms involved in tumorigenesis, as a result of EYA3 dephosphorylation of the specific substrate WDR1.

• Dr. Aura Ionescu
• PhD Adina Gabriela Puiu
• PhD Andrei Mihai Vasilescu

Eyes Absent protein 3 (EYA3), active c-Src, WDR1 as well as tyrosine phosphorylated form of WDR1 have been reported as playing important roles in breast cancer initiation, progression and metastasis. It has been also shown that protein tyrosine phosphatase activity of EYA3 mediates breast cancer cell migration, invasion, transformation and metastasis through an as yet unidentified mechanism. Our recently reported findings indicate that WDR1, a significant mediator of actin cytoskeleton reorganization i) is phosphorylated by active c-Src, ii) is an in vitro cytoplasmic substrate of EYA3 and iii) its dephosphorylation by EYA3 generates major changes to the cellular actin cytoskeleton. The central task of the present project is the in vivo validation of WDR1 dephosphorylation by EYA3 and identification of the downstream pathways. Initially, we will assess how the expression of EYA3, c-Src, WDR1 and the Tyr phosphorylation level of WDR1 correlate with the tumor-promoting effects in several representative breast cancer cell lines, what are WDR1/EYA3 interactors and what molecular mechanism(s) underly the identified correlations and interactions. Moreover, we wish to shed light on how the dephosphorylation of WDR1 by EYA3 is connected to Rho GTPase signaling pathways. Finally, we aim to elucidate the involvement of in vivo dephosphorylation of WDR1 by EYA3 in the tumorigenic properties of breast cancer cells using subcutaneous xenografted mice.

4. Design and laboratory experimentation of a molecular vector based on Holmium166 for re-diagnosis and targeted radiotherapy.

• Dr. Szedlacsek Horea
• PhD Adina Gabriela Puiu
• PhD Andrei Mihai Vasilescu

Our project is structured on three distinct panels of experimental development and applied research and has as final result the realization of a functional model of a neutron activator (NA) controlled by a cyclotron, to obtain a radiopharmaceutical based on an antibody coupled to an activated nanoparticle surface; the nanoparticles contain radionuclide that emits β Holmium-166 (t1 / 2 = 26.8 h), a type of radiation proven to be effective for targeted cancer therapy.

Financial resources:

·   Research Grant 548PED/2020-2022 from UEFISCDI for "Development of a functional model of a neutron activator (NA) controlled by a cyclotron to obtain a radiopharmaceutical based on an affibody coupled to a surface of activated nanoparticles", Partner (P) team, PN-III-P2-2.1-PED-2019-4184;

·  Research Grant 35PCCDI/2018-2021 from UEFISCDI for „Genomic mapping of population in area contaminated with radioactivity and heavy metals”, Partner 3, PN-III-P1-1.2-PCCDI-2017-0737;

·    Research Grant 64PCCDI/2018-2021 from UEFISCDI for „Development of radio-pharmaceuticals and nuclear technics in oncology for imaging and personalized therapy at molecular level”, Partner 1, PN-III-P1-1.2-PCCDI-2017-0769;

RECENT PUBLICATIONS

1.Analysis of EYA3 Phosphorylation by Src Kinase Identifies Residues Involved in Cell Proliferation.

Ionescu AE, Mentel M, Munteanu CVA, Sima LE, Martin EC, Necula-Petrareanu G, Szedlacsek SE.

Int J Mol Sci. 2019 Dec 13;20(24). pii: E6307. doi: 10.3390/ijms20246307.

2. Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation.

Manolache A, Selescu T, Maier GL, Mentel M, Ionescu AE, Neacsu C, Babes A, Szedlacsek SE.

J Cell Physiol. 2019 Nov 14. doi: 10.1002/jcp.29397. Published: June 2020

3. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer

    development.

Zimta AA, Schitcu V, Gurzau E, Stavaru C, Manda G, Szedlacsek S, Berindan-Neagoe I. Environ Res. 2019, Nov;178:108700. doi: 10.1016/j. Review.

4.    Crystal structure of a xylulose 5-phosphate phosphoketolase. Insights into the substrate specificity for xylulose 5-phosphate.

      Scheidig AJ, Horvath D, Szedlacsek SE. J Struct Biol. 2019 Jul 1;207(1):85-102.

5.    Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis.

Rosca AM, Mitroi DN, Cismasiu V, Badea R, Necula-Petrareanu G, Preda MB, Niculite C, Tutuianu R, Szedlacsek SE, Burlacu A. J.Cell.Mol.Med., 2018, 22(10), 4700-4708

6.      WDR1 is a novel EYA3 substrate and its dephosphorylation induces modifications of the cellular actin cytoskeleton.

Mentel M, Ionescu AE, Puscalau-Girtu I, Helm MS, Badea RA, Rizzoli SO, Szedlacsek SE. Sci Rep. 2018 Feb 13;8(1):2910.

7.      20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.

Tunaru S, Bonnavion R, Brandenburger I, Preussner J, Thomas D, Scholich K, Offermanns S. Nat Commun. 2018 Jan 12;9(1):177.

8.      Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.

Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Häussler A, Ferreiros N, Schiffmann S, Parnham MJ, Tunaru S, Chun J, Offermanns S, Foerch C, Scholich K, Vogt J, Wicker S, Lötsch J, Geisslinger G, Tegeder I. Acta Neuropathol Commun. 2017 Jun 2;5(1):42.

9.      The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.

Hohmann SW, Angioni C, Tunaru S, Lee S, Woolf CJ, Offermanns S, Geisslinger G, Scholich K, Sisignano M. Sci Rep. 2017 Mar 27;7(1):446.

10.  The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons.

Zinn S, Sisignano M, Kern K, Pierre S, Tunaru S, Jordan H, Suo J, Treutlein EM, Angioni C, Ferreiros N, Leffler A, DeBruin N, Offermanns S, Geisslinger G, Scholich K. J Biol Chem. 2017 Apr 14;292(15):6123-6134.

11.   Expression, Purification, and Kinetic Analysis of PTP Domains.

Mentel M, Badea RA, Necula-Petrareanu G, Mallikarjuna ST, Ionescu AE, Szedlacsek SE. Methods Mol Biol. 2016;1447:39-66.

12.    Arachidonic Acid Metabolite 19(S)-HETE Induces Vasorelaxation and Platelet Inhibition by Activating Prostacyclin (IP) Receptor.

Tunaru S, Chennupati R, Nüsing RM, Offermanns S. PLoS One. 2016 Sep 23;11(9):e0163633.

13.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes.

Tang C, Ahmed K, Gille A, Lu S, Gröne HJ, Tunaru S, Offermanns S. Nat Med. 2015 Feb;21(2):173-7.

14.  Phosphoketolases from Lactococcus lactis, Leuconostoc mesenteroides and Pseudomonas aeruginosa: dissimilar sequences, similar substrates but distinct enzymatic characteristics.

Petrareanu G, Balasu MC, Vacaru AM, Munteanu CV, Ionescu AE, Matei I, Szedlacsek SE. Appl Microbiol Biotechnol. 2014 Sep;98(18):7855-67.

15.  A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.

Preuss B, Tunaru S, Henes J, Offermanns S, Klein R. Clin Exp Immunol. 2014 Jul;177(1):179-89.

16.  Conserved MIP receptor-ligand pair regulates Platynereis larval settlement.

Conzelmann M, Williams EA, Tunaru S, Randel N, Shahidi R, Asadulina A, Berger J, Offermanns S, Jékely G. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8224-9.

17.  Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis.

Böhmer F, Szedlacsek S, Tabernero L, Ostman A, den Hertog J. FEBS J. 2013 Jan;280(2):413-31.

18.  Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors.

Tunaru S, Althoff TF, Nüsing RM, Diener M, Offermanns S. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9179-84.

• Alexandra Manolache, Tudor Selescu, G. Larisa Maier, Mihaela Mentel, Aura Elena Ionescu, Cristian Neacsu, Alexandru Babes, Stefan Eugen SzedlacsekAlexandra Manolache et al . Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation. Journal of Cellular Physiology, 2020, 235(6):5192-5203.IF=4.52
• Ionescu AE, Mentel M, Munteanu CVA, Sima LE, Martin EC, Necula-Petrareanu G, Szedlacsek SEIonescu AE et al . Analysis of EYA3 Phosphorylation by Src Kinase Identifies Residues Involved in Cell Proliferation. International Journal of Molecular Sciences, 2019, 20(24):6307.IF=4.18
• Scheidig AJ, Horvath D, Szedlacsek SE.Scheidig AJ et al . Crystal structure of a xylulose 5-phosphate phosphoketolase. Insights into the substrate specificity for xylulose 5-phosphate. Journal of Structural Biology, 2019, 207(1):85-102.IF=3.75
• Rosca AM, Mitroi DN, Cismasiu V, Badea R, Necula-Petrareanu G, Preda MB, Niculite C, Tutuianu R, Szedlacsek S, Burlacu ARosca AM et al . Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis. Journal of cellular and molecular medicine, 2018, 22(10):4700-4708.IF=4.66
• Mentel M, Ionescu AE, Puscalau-Girtu I, Helm MS, Badea RA, Rizzoli SO, Szedlacsek SEMentel M et al . WDR1 is a novel EYA3 substrate and its dephosphorylation induces modifications of the cellular actin cytoskeleton. Scientific reports, 2018, 8(1):2910.
• Mentel M, Badea RA, Necula-Petrareanu G, Mallikarjuna ST, Ionescu AE, Szedlacsek SEMentel M et al . Expression, Purification, and Kinetic Analysis of PTP Domains. Methods in molecular biology (Clifton, N.J.), 2016, 1447:39-66.
• Tanase CA. Histidine domain-protein tyrosine phosphatase interacts with Grb2 and GrpL. PloS one, 2010, 5(12):e14339.IF=4.41
• Pascaru M, Tanase C, Vacaru AM, Boeti P, Neagu E, Popescu I, Szedlacsek SEPascaru M et al . Analysis of molecular determinants of PRL-3. Journal of cellular and molecular medicine, 2009, 13(9B):3141-50.
• Thummel R, Li L, Tanase C, Sarras MP, Godwin ARThummel R et al . Differences in expression pattern and function between zebrafish hoxc13 orthologs: recruitment of Hoxc13b into an early embryonic role. Developmental biology, 2004, 274(2):318-33.
• Zhang J, Bai S, Tanase C, Nagase H, Sarras MP JrZhang J et al . The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos. Dev Genes, 2003, 8(213):382-9.